TKI-Resistant Renal Cancer Secretes Low-Level Exosomal miR-549a to Induce Vascular Permeability and Angiogenesis to Promote Tumor Metastasis

TKI-Resistant Renal Cancer Secretes Low-Level Exosomal miR-549a to Induce Vascular Permeability and Angiogenesis to Promote Tumor Metastasis

Tyrosine kinase inhibitors (TKI)-resistant renal cancer is highly susceptible to metastasis, and enhanced vascular permeability promotes the process of metastasis. To evaluate the effect of cancer-derived exosomes on vascular endothelial cells and clarify the mechanism of metastasis in TKI-resistant...

Full description

Bibliographic Details
Main Authors:	Zuodong Xuan, Chen Chen, Wenbin Tang, Shaopei Ye, Jianzhong Zheng, Yue Zhao, Zhiyuan Shi, Lei Zhang, Huimin Sun, Chen Shao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	TKI-resistant clear cell renal cell carcinoma exosome microRNA HIF1α vascular endothelial permeability
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2021.689947/full

Similar Items

Corrigendum: TKI-Resistant Renal Cancer Secretes Low-Level Exosomal miR-549a to Induce Vascular Permeability and Angiogenesis to Promote Tumor Metastasis
by: Zuodong Xuan, et al.
Published: (2021-07-01)

HIF-1α overexpression in mesenchymal stem cell-derived exosomes mediates cardioprotection in myocardial infarction by enhanced angiogenesis
by: Jiacheng Sun, et al.
Published: (2020-08-01)

Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant
by: Lihao Zhao, et al.
Published: (2019-12-01)

Circular RNA IARS (circ-IARS) secreted by pancreatic cancer cells and located within exosomes regulates endothelial monolayer permeability to promote tumor metastasis
by: Jie Li, et al.
Published: (2018-07-01)

Legal Protection of Indonesian Migrant Workers (TKI) Overseas (Case Study of BP3TKI North Sumatera Province)
by: Vinna Dinda Kemala, et al.
Published: (2020-01-01)

Emerging Therapies for Advanced Clear Cell Renal Cell Carcinoma
by: Alexander T. Toth, et al.
Published: (2020-12-01)

Oncogenic miR-27a delivered by exosomes binds to SFRP1 and promotes angiogenesis in renal clear cell carcinoma
by: Yi Hou, et al.
Published: (2021-06-01)

Hypoxic exosomes orchestrate tumorigenesis: molecular mechanisms and therapeutic implications
by: Reza Jafari, et al.
Published: (2020-12-01)

HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma
by: Maroto P, et al.
Published: (2017-09-01)

Mechanism of Sanguinarine in Inhibiting Macrophages to Promote Metastasis and Proliferation of Lung Cancer via Modulating the Exosomes in A549 Cells
by: Yu Y, et al.
Published: (2020-09-01)

Response to HER2 Inhibition in a Patient With Brain Metastasis With EGFR TKI Acquired Resistance and an HER2 Amplification
by: Arenda D. Meedendorp, et al.
Published: (2018-05-01)

Research Progress of Mechanisms on Intracranial Metastasis of Non-small Cell Lung Cancer after Clinical Benefit from EGFR-TKI
by: Juan JIANG, et al.
Published: (2015-08-01)

The Association Between Ascorbate and the Hypoxia-Inducible Factors in Human Renal Cell Carcinoma Requires a Functional Von Hippel-Lindau Protein
by: Christina Wohlrab, et al.
Published: (2018-11-01)

Wacana TKI dalam Novel Jatisaba Karya Ramayda Akmal
by: Muchlas Abror
Published: (2020-08-01)

Effects of 17-DMAG on Non-small Cell Lung Cancer Cell Lines A549 and H1975 Being Resistant to EGFR-TKI
by: Lei ZHAO, et al.
Published: (2014-11-01)

Increased HIF-1alpha And VEGF Expression Found in Various T Stages of Clear Cell Renal Cell Carcinoma
by: Yohana Octavianda, et al.
Published: (2018-07-01)

IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways
by: Xiaomeng Wang, et al.
Published: (2019-11-01)

The role of tumor-derived exosomes in tumor angiogenesis and tumor progression
by: Gluszko Alicja, et al.
Published: (2019-12-01)

Effect of Exosomal APE1 on Sensitivity of NSCLC A549 Cells to Cisplatin
by: DAI Nan, et al.
Published: (2020-07-01)

PUDARNYA KONSEP DIRI: Jeritan Psikologis Siswa Anak TKI SMPN 04 Bandar Batang
by: Maskhur *, et al.
Published: (2013-05-01)

PERLINDUNGAN TENAGA KERJA INDONESIA (TKI) DI LUAR NEGERI OLEH PERWAKILAN REPUBLIK INDONESIA
by: Peni Susetyorini
Published: (2010-01-01)

EGFR-TKI plus bevacizumab versus EGFR-TKI monotherapy for patients with EGFR mutation-positive advanced non-small cell lung cancer-A propensity score matching analysis
by: Jeng-Shiuan Tsai, et al.
Published: (2021-09-01)

Pathological complete response of renal cell carcinoma with vena cava tumor thrombus to neoadjuvant TKI/IO combination therapy
by: Takuto Hara, et al.
Published: (2021-11-01)

Concurrent use of anlotinib overcomes acquired resistance to EGFR‐TKI in patients with advanced EGFR‐mutant non‐small cell lung cancer
by: Chen Zhang, et al.
Published: (2021-10-01)

Downregulation of exosomal CLEC3B in hepatocellular carcinoma promotes metastasis and angiogenesis via AMPK and VEGF signals
by: Wenjuan Dai, et al.
Published: (2019-09-01)

The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What’s the Story Morning Glory?
by: Andrea Marchetti, et al.
Published: (2021-06-01)

Studi Moratorium Sebagai Upaya Perlindungan Pengiriman TKI Berdasarkan UU No. 39 tahun 2004 di Madura
by: devi rahayu
Published: (2017-01-01)

EGFR‐mutated stage IV non‐small cell lung cancer: What is the role of radiotherapy combined with TKI?
by: Bailong Liu, et al.
Published: (2021-09-01)

Expression of ARL4C in Non-small Cell Lung Cancer and Its Role in EGFR-TKI Resistance
by: CHEN Zeng, et al.
Published: (2020-07-01)

The prognostic impact of neutrophil to lymphocyte ratio in advanced non-small-cell lung cancer patients treated with EGFR TKI
by: Phan TT, et al.
Published: (2018-11-01)

Clinical Developments for the EGFR-TKI Combined with Radiotherapy in Advanced Non-small Cell Lung Cancer
by: Xianan LI, et al.
Published: (2014-04-01)

Exosomes of human placenta-derived mesenchymal stem cells stimulate angiogenesis
by: Motohiro Komaki, et al.
Published: (2017-10-01)

Effect of EGFR-TKI on Lymphangiogenesis of Lung Cancer with EGFR Mutation
by: Minghui CAI, et al.
Published: (2014-12-01)

Surgical resection of advanced non-small cell lung cancer after a response to EGFR-TKI: presentation of two cases and a literature review
by: Yoko Yamamoto, et al.
Published: (2017-11-01)

Molecular Mechanism and Progression of Primary Resistance to EGFR-TKI - Analysis of 2 Cases
by: Meirong LIU, et al.
Published: (2019-01-01)

The Role of Angiogenesis and Pro-Angiogenic Exosomes in Regenerative Dentistry
by: Alina-Andreea Zimta, et al.
Published: (2019-01-01)

EGFR-TKI ADR Management Chinese Expert Consensus
by: Chinese Society of Lung Cancer, Chinese Anti-Cancer Association
Published: (2019-02-01)

COMPARISON OF CHEMOTHERAPY RESPONSE AND ADVERSE EFFECTS OF DOUBLE-PLATINUM PLUS EGFR-TKI VERSUS DOUBLE-PLATINUM ALONE ON NSLCLC PATIENTS WITH DISEASE PROGRESSION AND EGFR-TKI TREATMENT
by: Laksmi Wulandari, et al.
Published: (2017-12-01)

Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non‐small cell lung cancer receiving EGFR‐TKI treatment
by: Norimitsu Kasahara, et al.
Published: (2020-08-01)

Exosomes and Cell Communication: From Tumour-Derived Exosomes and Their Role in Tumour Progression to the Use of Exosomal Cargo for Cancer Treatment
by: Andrea Nicolini, et al.
Published: (2021-02-01)